François B, Garcia Sanchez M, Eggimann P, et al. Suvratoxumab reduces staphylococcus aureus pneumonia in high-risk icu patients: results of the SAATELLITE Study. Am J Resp Crit Care Med. 2019;199:A7358.
Post-tuberculosis lung disease vraagt om alertheid in de eerstelijn
apr 2026 | Bacteriële infecties, Tuberculose